Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yan Song's publication output changed over time?
ScholarIQpublication output · 2010–2024
Output grew0% over the shown period — from 1 works in 2010 to 1 in 2024.
1
1
1
3
1
1
2
1
20102011201620192020202120222024
What are the most-cited papers on Yan Song?
ScholarIQmost cited works
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Yan Song, M. Kay Washington, Howard C. Crawford
Cancer Research. 2010260 CitationsOPEN ACCESS
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
Jing Huang, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Yan Song, Jie He
Cancer Medicine. 2021117 CitationsOPEN ACCESS
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Aiping Zhou, Yuxian Bai, Yan Song, Hong Luo, Xiu-Bao Ren, Xiuwen Wang, Benkang Shi, Cheng Fu, Ying Cheng, Jiyan Liu, Shukui Qin, Jun Li, Hanzhong Li, Xianzhong Bai, Dingwei Ye, Jinwan Wang, Jianhui Ma
The Oncologist. 2019115 CitationsOPEN ACCESS
PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance
Nilotpal Roy, Kenneth K. Takeuchi, Jeanine Ruggeri, Peter J. Bailey, David K. Chang, Joey H. Li, Laura Leonhardt, Sapna Puri, Megan T. Hoffman, Shan Gao, Christopher J. Halbrook, Yan Song, Mats Ljungman, Shivani Malik, Christopher V.E. Wright, David W. Dawson, Andrew V. Biankin, Matthias Hebrok, Howard C. Crawford
S168778273. 2016105 CitationsOPEN ACCESS
What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China
Puyuan Xing, Yixiang Zhu, Le Wang, Zhouguang Hui, Shangmei Liu, Jiansong Ren, Ye Zhang, Yan Song, Chengcheng Liu, Yunchao Huang, Xianzhen Liao, Xiaojing Xing, Debin Wang, Li Yang, Lingbin Du, Yu‐Qin Liu, Yongzhen Zhang, Yun‐Yong Liu, Donghua Wei, Kai Zhang, Jufang Shi, You‐Lin Qiao, Wanqing Chen, Junling Li, Min Dai, the LuCCRES Group
Cancer Medicine. 201980 CitationsOPEN ACCESS
Related on ScholarIQ
Hubei University of Science and Technology
Institution
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Paper
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
Paper
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Paper
PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance
Paper
What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China
Paper